Navigation Links
Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on Nexavar; Previously Announced Fourth Quarter and Full Year 2007 Financial Results Teleconference Rescheduled
Date:2/18/2008

EMERYVILLE, Calif., Feb. 18 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will webcast a teleconference with management to provide an update on Nexavar(R) (sorafenib) tablets, as well as to discuss fourth quarter and full year 2007 financial results, on Tuesday, February 19, 2008, at 10:00 a.m. Eastern Time (7:00 a.m. Pacific Time). This teleconference will replace the one previously scheduled for later in the day. Financial results for the fourth quarter and year ended December 31, 2007 will be released earlier that day.

Interested parties may access a live webcast of the presentation on our website at: http://www.onyx-pharm.com/wt/page/event_calendar or by dialing 847-413-3238 and using the passcode 20751832. A replay of the presentation will be available on the Onyx website or by dialing 630-652-3044 and using the passcode 20751832 approximately one hour after the teleconference concludes. The replay will be available through March 19, 2008.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer by changing the way cancer is treated(TM). The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar(R) (sorafenib) tablets, a small molecule drug. Nexavar is currently approved for the treatment of advanced kidney cancer and for the treatment of liver cancer. Additionally, Nexavar is being investigated in several ongoing trials in non-small cell lung cancer, melanoma, breast cancer and other tumor types. For more information about Onyx, visit the company's website at:

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Toronto, Ontario (PRWEB) August 28, 2014 ... and supply company in North America, today announced the ... that makes doing business with Canadian Linen even ... tool allows customers to access account information online and ... new customer portal include the ability to:, ...
(Date:8/28/2014)... Parker Waichman LLP, a national personal ... to ensure that the heroes of 9/11 are never ... WTC victims who developed 9/11-related cancer was reaffirmed by ... (GAO). According to a statement issued by 9/11 ... entitled “World Trade Center Health Program: Approach Used to ...
(Date:8/28/2014)... Watertown, MA (PRWEB) August 28, 2014 ... , is delighted to present its new Kids’ Share, which ... Share will encourage kids (and their parents) to get into ... their very own vegetable share. Each week the Kids’ Share ... fabulous veggies, shares will include activities for kids, recipes from ...
(Date:8/28/2014)... 2014 Clarity PSO , an ... as a federal Patient Safety Organization (PSO) for another ... Healthcare Research and Quality (AHRQ). Clarity PSO will continue ... services following the true intentions of the Patient Safety ... are proud and eager to continue our journey as ...
(Date:8/28/2014)... 2014 (HealthDay News) -- Having greater amounts of yellow ... see distant objects in hazy conditions, a new study ... researchers simulated hazy conditions in order to test the ... pigment (also called macular pigment) in their eyes. ... which represents accumulations of the nutrients lutein and zeaxanthin, ...
Breaking Medicine News(10 mins):Health News:Canadian Linen and Uniform Service Launches New Customer Portal 2Health News:Canadian Linen and Uniform Service Launches New Customer Portal 3Health News:GAO Report Reaffirms Decision to Add Cancers to List of Illnesses Covered under the Zadroga Act, Parker Waichman LLP Comments 2Health News:GAO Report Reaffirms Decision to Add Cancers to List of Illnesses Covered under the Zadroga Act, Parker Waichman LLP Comments 3Health News:Kids Don't Have to Share Their Vegetables, Thanks to Siena Farms, ChopChop Magazine & Chef Ana Sortun 2Health News:Kids Don't Have to Share Their Vegetables, Thanks to Siena Farms, ChopChop Magazine & Chef Ana Sortun 3Health News:Kids Don't Have to Share Their Vegetables, Thanks to Siena Farms, ChopChop Magazine & Chef Ana Sortun 4Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 2Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 3Health News:Eye Pigment May Help Vision in Hazy Conditions 2
... 18 One year ago today, the,American people ... and outpatient facilities treating wounded soldiers returning,from Iraq ... those,reports, John McCain saw an opportunity to bolster ... blamed the scandal on former,Secretary of Defense Don ...
... Rep. Jason Altmire,(D-PA) will experience the vital and expanding ... of the clinical laboratory facilities,at Magee-Womens Hospital Tuesday, Feb. ... the 5:30 P.M. tour for,Rep. Altmire, who will view ... "Magee-Womens Hospital,s ongoing leadership in improving health care,for ...
... ALAMOS, N.M., Feb. 18 Meat & Livestock ... techniques for,high-speed CT scans of livestock carcasses. Using ... will begin Phase 1 of a,multi-year, 6 phase ... production CT applications include the potential to scan ...
... be,prepared and take action., That,s the advice ... tragedies like the one recently at Northern Illinois ... of K-State,s College of,Human Ecology and associate professor ... Research, Education and Consultation at K-State, or TRECK,Team., ...
... Spanish . , ANN ARBOR, Mich. People taking ... their symptoms during the first few months, but lagging behind ... research from the University of Michigan Health System. , That ... hopelessness even while their condition is improving, which could lead ...
... Feb. 18 Darwin,Professional Underwriters, Inc. (Darwin), ... its lawyers professional liability policy. Limits of ... from one to one hundred attorneys. All,areas ... maintains a particular,focus on plaintiff,s personal injury ...
Cached Medicine News:Health News:Walter Reed Anniversary Exposes More McCain Double Talk 2Health News:Walter Reed Anniversary Exposes More McCain Double Talk 3Health News:Congressman Altmire Tours Women's Health Clinical Laboratory; Learns Vital Role in Patient Care 2Health News:IMTEC to Become Technology Solutions Provider for Meat & Livestock Australia 2Health News:K-State Trauma Researcher Says Being Prepared, Taking Action Are Vital in Preventing Tragedies Like the One at NIU 2Health News:As depression symptoms improve with antidepressants, hopelessness can linger 2Health News:Darwin Introduces Enhancements to its Lawyers Professional Liability Insurance Policy Including Privacy Wrongful Acts and More 2Health News:Darwin Introduces Enhancements to its Lawyers Professional Liability Insurance Policy Including Privacy Wrongful Acts and More 3
(Date:8/28/2014)... Aug. 28, 2014  Decision Resources Group finds that the ... around $7.7 billion by 2023 in the United ... Germany , Italy , ... and Japan . The biosimilar erosion of ... balanced out by the launch of Eli Lilly,s Cyramza, Taiho ...
(Date:8/28/2014)... 2014 Levi & Korsinsky announces that a ... States District Court for the District of ... Galectin Therapeutics Inc. ("Galectin" or the "Company") (NasdaqCM: GALT) ... For more information, click here: http://zlk.9nl.com/galectin-therapeutics-galt ... Class Period the Company violated federal securities laws by ...
(Date:8/28/2014)... Nonin Medical, Inc., the inventor of finger pulse oximetry ... that the Food and Drug Administration (FDA) has cleared ... use in the United States . ... or kiosk through a USB connector and measures oxygen ... The Model 3231 received EU certification last year. ...
Breaking Medicine Technology:The Colorectal Cancer Market Will Remain Steady at $7.7 Billion by 2023, With Biosimilar Erosion Of Key Agents Being Balanced Out By the Launch Of Premium-Priced Therapies 2SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT 2Nonin Medical Announces FDA Clearance of Nonin Model 3231 USB Pulse Oximeter 2
... 15, 2012 Senior representatives from leading pharmaceutical ... Novartis MIT will meet at the Pharma Qbd Forum in ... to share their expert knowledge on how Quality by Design ... the main points of discussion will be the findings of ...
... Feb. 14, 2012  At a meeting held today, the Directors ... per share. The dividend is payable on March 15, 2012 ... About Sigma-Aldrich :  Sigma-Aldrich ... High Technology company whose biochemical, organic ...
Cached Medicine Technology:Understand the Lessons Learned from the FDA QbD Pilot Programme - Case Study Merck Serono 2
... mechanism for speed, stability and durability. ... display modes, multiple units of measure, ... auto print, and GLP/GMP/ISO output including ... clock. Built-in, motor-driven internal calibration ...
TOPLOAD 3200/0.01G, BL3200H. Touch-key external calibration only. Requires calibration weights (either 2000g or 3000g). 120/240V A/C adapter, Lock-down Ring, In-use Protective Cover....
... Portable - Battery Powered (6 size AA ... conversion (g, ct, oz, ozt, GN, dwt, ... Counting and Percent Measure functions, Auto Print. ... Optional AC adapter may be ordered for ...
... BX620S. Digital stability control, analog display ... counting and percent measure functions, auto ... and time data from built-in clock. ... (selectable from 200g to 600g). Built-in ...
Medicine Products: